منو
رکورد قبلیرکورد بعدی

" Immunotherapy of renal cell carcinoma : "


Document Type : BL
Record Number : 721887
Doc. No : b541595
Main Entry : F.M.J. Debruyne [and others] (eds.) ; with the assistance of R.J.A. van Moorselaar ; with contributions by R. Ackermann [and others].
Title & Author : Immunotherapy of renal cell carcinoma : : clinical and experimental developments\ F.M.J. Debruyne [and others] (eds.) ; with the assistance of R.J.A. van Moorselaar ; with contributions by R. Ackermann [and others].
Publication Statement : Berlin ; New York: Springer-Verlag, ©1991.
Page. NO : ix, 141 pages ; 25 cm
ISBN : 0387528350
: : 3540528350
: : 9780387528359
: : 9783540528357
Contents : Experimental Data.- Considerations in Immunotherapy of Genitourinary Neoplasia.- Murine Renal Cancer (Renca) Model: Background and Preclinical Studies.- Renal Cell Carcinoma: Experimental Metastases.- Oncogenes in Renal Cell Carcinoma.- Molecular Basis and Clinical Relevance of MDR1 Gene Expression in Renal Cell Carcinoma.- Radioimmunoconjugates in Renal Cell Carcinoma.- Interferon and Tumor Necrosis Factor in Renal Cell Carcinoma Model Systems.- Clinical Experience with Biological Response Modifiers in Renal Cell Carcinoma.- Rationale for Immunotherapy in Renal Cell Carcinoma.- Treatment of Renal Cell Carcinoma with Interferon.- Combination Therapy with Interferon in Renal Cell Carcinoma.- Recombinant Interferon Alpha Plus Vinblastine in Metastatic Renal Cell Cancer: Updated Results.- Monotherapy and Combination Therapy with Interferon-?, Interferon-?, and Tumor Necrosis Factor-? in Metastatic Renal Cell Carcinoma.- Treatment of Advanced Renal Cell Carcinoma by Systemic Low-Dose Recombinant Interleukin-2.- Direct Lymphatic Immunotherapy for Metastatic Renal Cell Carcinoma.- Combination Therapy of Renal Cell Carcinoma with Interleukin-2 and Interferon Alpha: The Cleveland Clinic Experience.- Tumor Infiltrating Lymphocytes in Human Renal Cell Carcinoma: Adoptive Immunotherapy and Characterization of Interleukin-2 Expanded Tumor-Infiltrating Lymphocytes.- Active Specific Immunotherapy in Renal Cell Carcinoma: Optimization.
Subject : Immunothérapie.
Subject : Néphrocarcinome -- Thérapeutique.
Subject : Renal cell carcinoma -- Immunotherapy.
LC Classification : ‭RC280.K5‬‭F553 1991‬
Added Entry : F M J Debruyne
: R Ackermann
copyhttps://lib.clisel.com/site/catalogue/721887
کپی لینک
پیشنهاد خرید
پیوستها
Search result is zero
نظرسنجی
نظرسنجی منابع دیجیتال

1 - آیا از کیفیت منابع دیجیتال راضی هستید؟